SC-DARIC33
PLAT-08
Phase 1 mab active
Quick answer
SC-DARIC33 for Acute Myeloid Leukemia is a Phase 1 program (mab) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- active